The Industry

December 2007
Pharmaceutical Representative;Dec2007, Vol. 37 Issue 12, p10
The article offers world news briefs related to pharmaceutical industry. Auriga Laboratories Inc. of Los Angeles, California increased its sales force from 228 sales associates in June 2007 to 325. King Pharmaceuticals of Bristol, England, reveals plans to cut about 20% of its workforce and focus on neuroscience and hospital care. The Japanese Ministry of Health and Welfare approved the use of tarceva in treating nonresectable, recurrent and advanced non-small cell lung cancer.


Related Articles

  • Japanese National Physical Activity and Health Promotion Guidelines. Ohta, Toshiki; Tabata, Izumi; Mochizuki, Yumiko // Journal of Aging & Physical Activity;Jul1999, Vol. 7 Issue 3, p231 

    Presents a translation of the Japanese Physical Activity and Health Promotion Guidelines formulated by the Japanese Ministry of Health and Welfare. Definition of physical activity; Objectives of physical activity; Discussion on the health principles adopted by the Japanese.

  • FDA-style agency for Japan. Saegusa, Asako // Nature Biotechnology;Jan1999, Vol. 17 Issue 1, p7 

    Reports on the merger of the pharmaceutical and medical safety bureau and the environmental health bureau by Japan's Ministry of Health and Welfare. Aim of the merger to create an agency modeled on the US food and Drug Administration; Description of the job responsibility of the agency;...

  • NOW AVAILABLE.  // Drug Topics;4/2/2007, Vol. 151 Issue 7, p51 

    The article evaluates the Aquoral medicine from Auriga Laboratories Inc.

  • Xylitol approved in Japan.  // Dairy Industries International;Sep97, Vol. 62 Issue 9, p13 

    Reports on the approval of Xylitol as a food additive by the Japanese Ministry of Health and Welfare. Information on Xylitol; Expected impact of Xylitol on the sugar free market in Japan.

  • Japan to train 40,000 as nursing specialist by 2000.  // Australian Nursing Journal;Mar1998, Vol. 5 Issue 8, p15 

    Reports that according to the Nihon Keizai, the Japanese Ministry of Health and Welfare will train 40,000 nursing specialists to design health care programs. What the training coincides with; Who would be eligible for the positions; Jobs of the specialists.

  • Japan plans improved monitoring of new drugs. Lamar, Joe // BMJ: British Medical Journal (International Edition);06/10/2000, Vol. 320 Issue 7249, p1560 

    Reports that the health ministry of Japan will ask pharmaceutical companies to monitor the side effects of drugs under plans it has submitted to politicians and industry leaders as of June 2000. Bases for the monitoring; Details on the submitted plans.

  • Pipeline.  // Medical Marketing & Media;Dec2007, Vol. 42 Issue 12, p10 

    The article offers updates related to drug developments in the U.S. The Allergan Inc. has received the Food and Drug Administration's approval for Combigan for the reduction of elevated intraocular pressure in patients with glaucoma. The Auriga Laboratories Inc. launched the Coraz Lotion, which...

  • The trust factor. Sandroff, Ronni // Consumer Reports on Health;Aug2004, Vol. 16 Issue 8, p2 

    Discusses health issues in the U.S. Amount spent by drug manufacturers on sampling and detailing to doctors in 2001; View of newsletter readers in Phoenix on visits by drug salespeople; Factors that can improve the trust in the patient-doctor relationship.

  • US wards off generic competition, while Japan considers embracing it.  // PharmacoEconomics & Outcomes News;6/18/2005, Issue 480, p18 

    Reports on the plan of U.S. pharmaceutical companies to pursue line extensions of products to address competition from generic versions according to the study "Combating Generics: Pharmaceutical Brand Defense" from pharmaceutical research firm Cutting Edge Information. Percentage of companies...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics